Matches in Nanopublications for { ?s ?p "[At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_assertion description "[At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- NP854431.RAnqfn24gYZldLyFz2Sd2Sv2idIoR_I9lIQgVCNhFcGqw130_assertion description "[At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854431.RAnqfn24gYZldLyFz2Sd2Sv2idIoR_I9lIQgVCNhFcGqw130_provenance.
- NP894059.RA9pCWBDMtsXfxQzztdOEu1Tvsmdu-MWWbT4W1ryVcXgo130_assertion description "[At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894059.RA9pCWBDMtsXfxQzztdOEu1Tvsmdu-MWWbT4W1ryVcXgo130_provenance.
- NP664882.RAI0z7cNWzO6ExDrFjVL9w6YjzwD57db-mcRIsRSp2AtQ130_assertion description "[At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664882.RAI0z7cNWzO6ExDrFjVL9w6YjzwD57db-mcRIsRSp2AtQ130_provenance.